Back to Search
KARL PAPPA, M.D.
M.D.
Ophthalmology Physician
NPI: 1760452338IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
35057154 P(OH)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 1987
Research & Publications (19)
Human microRNA target analysis and gene ontology clustering by GOmir, a novel stand-alone application.
PMID 19534746·BMC Bioinformatics·2009
8-other
Novel sources of fetal stem cells: where do they fit on the developmental continuum?
PMID 19438317·Regen Med·2009
6-review
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
PMID 19320570·AIDS Res Hum Retroviruses·2009
4-observational
Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations.
PMID 18771059·Antivir Ther·2008
5-case
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
PMID 18373851·AIDS Res Ther·2008
8-other
Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.
PMID 18047393·Stem Cells Dev·2007
8-other
Intermediate metabolism in association with the amino acid profile during the third trimester of normal pregnancy and diet-controlled gestational diabetes.
PMID 17240238·Am J Obstet Gynecol·2007
8-other
Plasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteers.
PMID 17088488·Antimicrob Agents Chemother·2007
3-trial
Evolution of HIV resistance mutations in patients maintained on a stable treatment regimen after virologic failure.
PMID 17075391·J Acquir Immune Defic Syndr·2006
8-other
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity.
PMID 16420253·HIV Med·2006
3-trial
Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status.
PMID 16256179·Gynecol Oncol·2006
8-other
Emerging issues of the expression profiling technologies for the study of gynecologic cancer.
PMID 16157086·Am J Obstet Gynecol·2005
6-review
Gestational diabetes exhibits lack of carnitine deficiency despite relatively low carnitine levels and alterations in ketogenesis.
PMID 15804790·J Matern Fetal Neonatal Med·2005
8-other
Congenital bronchopulmonary sequestration presenting as a thoracic tumor: a case report.
PMID 15597859·Eur J Gynaecol Oncol·2004
5-case
Y chromosomal haplogroup J as a signature of the post-neolithic colonization of Europe.
PMID 15322918·Hum Genet·2004
8-other
Disuniting uniformity: a pied cladistic canvas of mtDNA haplogroup H in Eurasia.
PMID 15254257·Mol Biol Evol·2004
8-other
The western and eastern roots of the Saami--the story of genetic "outliers" told by mitochondrial DNA and Y chromosomes.
PMID 15024688·Am J Hum Genet·2004
8-other
Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients.
PMID 12795812·BMC Infect Dis·2003
3-trial
Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters.
PMID 12097761·Respiration·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 262 NEIL AVE STE 320
COLUMBUS, OH 43215 - Phone
- (614) 228-4500
Quick Facts
- NPI
- 1760452338
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 39
- Publications
- 19
Are you this provider?
Claim Your Profile